Verona Pharma PLC (LSE:VRP) People

Verona Pharma PLC

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Mark W Hahn
Other companies: Soleno Therapeutics, Inc. (Director · Since at least Oct 13, 2025); ALSP Orchid Acquisition I Corp (Director · Nov 18, 2021 – Nov 18, 2021 · Past); Dova Pharmaceuticals Inc (Chief Financial Officer · Jan 31, 2018 – Nov 12, 2019 · Past); Cempra Inc (EVP and CFO · Feb 2, 2012 – Feb 23, 2017 · Past)
Chief Financial Officer · Since at least Jan 1, 2021
Vikas Sinha
Other companies: Scholar Rock Holding Corporation (Chief Financial Officer · Since at least Apr 27, 2025); BCLS Acquisition Corp (Director · Oct 22, 2020 – Oct 22, 2020 · Past); Kalaris Therapeutics, Inc. (See Remarks, Director · Jul 29, 2020 – Feb 21, 2025 · Past); Alexion Pharmaceuticals Inc (EVP & CFO · Jul 12, 2013 – Aug 8, 2016 · Past)
Director · Since at least Jan 1, 2021
David Zaccardelli
Other companies: Vor Biopharma Inc. (Director · Since at least Jul 7, 2026); SAB Biotherapeutics, Inc. (Chair of the Board · Since at least Jan 5, 2026)
President and CEO, Director · Since at least Aug 7, 2024
James Brady
Other companies: Xeris Biopharma Holdings, Inc. (Independent, Non-executive Board Member · Since at least Mar 28, 2025)
Director · Since at least Mar 14, 2022
Anders UllmanDirector · Since at least Jan 1, 2021
Andrew FisherGeneral Counsel · Since at least Mar 4, 2024
David R EbsworthDirector · Since at least Jan 1, 2021
Kathleen A RickardChief Medical Officer · Since at least Jan 1, 2021
Kenneth CunninghamDirector · Since at least Jan 1, 2021
Lisa DeschampsDirector · Since at least Mar 1, 2021
Martin EdwardsDirector · Since at least Apr 25, 2025
Michael AustwickDirector · Since at least Feb 1, 2024